The performance of the PedsQL generic core scales in children with sickle cell disease

Julie A Panepinto1, Nicholas M Pajewski, Lisa M Foerster

  • 1Department of Pediatrics, Hematology/Oncology/Bone Marrow Transplantation, Children's Hospital of Wisconsin of the Children's Research Institute, Milwaukee, WI 53226, USA. jpanepin@mcw.edu

Insights

The Pediatric Quality of Life Inventory (PedsQL) questionnaire is a feasible, reliable, and valid tool for measuring health-related quality of life in children with sickle cell disease.

Area of Science:

  • Pediatric Health
  • Hematology
  • Quality of Life Research

Background:

  • Sickle cell disease significantly impacts children's health-related quality of life (HRQL).
  • Accurate measurement of HRQL is crucial for managing pediatric sickle cell disease.
  • Validated instruments are needed to assess HRQL in this population.

Purpose of the Study:

  • To evaluate the feasibility, reliability, and validity of the Pediatric Quality of Life Inventory (PedsQL) generic core scales.
  • To assess the PedsQL's utility in distinguishing HRQL between children with and without sickle cell disease.
  • To determine if the PedsQL can differentiate between varying severities of sickle cell disease.

Main Methods:

  • Cross-sectional study involving children aged 2-18 years from sickle cell disease and primary care clinics.
  • Health-related quality of life (HRQL) assessed using the PedsQL questionnaire (parent proxy-report and child self-report).
  • Feasibility assessed by missing item analysis; reliability by Cronbach's alpha; validity by comparing groups and disease severity.

Main Results:

  • The PedsQL questionnaire demonstrated feasibility and reliability in children with sickle cell disease.
  • Both parent proxy and child self-reports effectively differentiated children with and without sickle cell disease.
  • Parent proxy-reports accurately distinguished between mild and severe sickle cell disease.

Conclusions:

  • The PedsQL questionnaire is a feasible, reliable, and valid instrument for measuring HRQL in children with sickle cell disease.
  • The PedsQL facilitates the assessment of HRQL across different disease severities.
  • This tool supports comprehensive care and research for pediatric sickle cell disease.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...